UF EPI expert explains measles as U.S. outbreaks hit 1,000 cases
University of Florida Emerging Pathogens Institute expert explains measles as U.S. outbreaks breach 1,000 cases for the second time this century.
Posts tagged as
Vaccine
High COVID-19 viral exposure may reduce protection provided by vaccination and prior infection
New research reveals that intense COVID-19 viral exposure may diminish the shielding effects of vaccination and previous infection, resulting in “leaky” protection.
UF expert answers questions about the newly approved RSV vaccine
On May 3, the FDA approved a vaccine to prevent respiratory syncytial virus in older adults. Dr. Cindy Prins answers some common questions about RSV disease and the new vaccine.
Greater public health response needed to limit monkeypox’s evolution, experts say
UF biostatistician Ira Longini offers an expert opinion in The Lancet, along with colleagues, on the role of vaccination in reducing monkeypox viral evolution.
Modeling Covid-19 vaccination efforts in the U.S.
Recent work contributed to by UF mathematician Burton Singer seeks to estimate how COVID-19 vaccination campaigns will affect the future trajectory of the pandemic in the US.
New malaria vaccine candidate seeks to block transmission
Two new studies advance a potentially groundbreaking transmission-blocking malaria vaccine. UF researcher Rhoel Dinglasan's approach is completely different: Immunizing mosquitoes with malaria transmission-blocking antibodies produced in people.
Covid-19 vaccine effective against new variant in Brazil
UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.
UF researcher’s “mop up” malaria vaccine funded for trials in people
A malaria vaccine designed by UF professor Rhoel Dinglasan is expected to advance to phase 1 clinical trials, thanks to new funding. The vaccine is designed differently from all others: It immunizes mosquitoes via people.
Partial dose of Yellow Fever vaccine works in emergencies
UF researchers contributed to a clinical trial that found using one-fifth of a standard dose of yellow fever vaccine is an effective strategy for emergency outbreak scenarios.
Universal flu vaccine worth every cent
New modeling by EPI researcher Burton Singer calculates that the substantial costs involved in developing a universal flu vaccine are worth every cent. Singer collaborated with a team from Yale University, University of Texas at Austin, and the University of Maryland to calculate that a universal flu vaccine would save $3.5 billion in direct medical costs annually and save 19,500 lives in the U.S. alone.
